Health Insurance Innovations Inc (HIIQ) CTO Sheldon Wang Sells 5,000 Shares
Health Insurance Innovations Inc (NASDAQ:HIIQ) CTO Sheldon Wang sold 5,000 shares of the company’s stock in a transaction dated Wednesday, December 13th. The shares were sold at an average price of $25.00, for a total transaction of $125,000.00. Following the completion of the sale, the chief technology officer now owns 194,001 shares in the company, valued at approximately $4,850,025. The sale was disclosed in a filing with the SEC, which is accessible through this link.
Sheldon Wang also recently made the following trade(s):
- On Friday, December 15th, Sheldon Wang sold 5,000 shares of Health Insurance Innovations stock. The shares were sold at an average price of $27.40, for a total transaction of $137,000.00.
Health Insurance Innovations Inc (HIIQ) traded down $0.65 on Friday, reaching $26.90. 994,249 shares of the company traded hands, compared to its average volume of 398,644. The firm has a market capitalization of $455.70, a price-to-earnings ratio of 18.74 and a beta of 0.65. Health Insurance Innovations Inc has a 52-week low of $12.65 and a 52-week high of $37.38.
Health Insurance Innovations (NASDAQ:HIIQ) last released its quarterly earnings data on Wednesday, November 1st. The financial services provider reported $0.46 earnings per share for the quarter, topping the consensus estimate of $0.35 by $0.11. The firm had revenue of $63.34 million for the quarter, compared to analyst estimates of $59.30 million. Health Insurance Innovations had a net margin of 5.98% and a return on equity of 21.32%. Health Insurance Innovations’s quarterly revenue was up 37.4% on a year-over-year basis. During the same quarter in the prior year, the business earned $0.33 earnings per share. analysts anticipate that Health Insurance Innovations Inc will post 1.39 EPS for the current fiscal year.
Health Insurance Innovations announced that its board has authorized a stock repurchase program on Monday, October 16th that allows the company to buyback $50.00 million in outstanding shares. This buyback authorization allows the financial services provider to buy shares of its stock through open market purchases. Stock buyback programs are typically an indication that the company’s leadership believes its shares are undervalued.
Institutional investors and hedge funds have recently added to or reduced their stakes in the stock. Morgan Stanley raised its stake in Health Insurance Innovations by 240.2% during the first quarter. Morgan Stanley now owns 70,397 shares of the financial services provider’s stock worth $1,127,000 after acquiring an additional 49,703 shares during the period. Argent Capital Management LLC grew its position in Health Insurance Innovations by 34.5% in the 2nd quarter. Argent Capital Management LLC now owns 175,975 shares of the financial services provider’s stock worth $4,135,000 after purchasing an additional 45,100 shares during the last quarter. Emerald Mutual Fund Advisers Trust grew its position in Health Insurance Innovations by 3.1% in the 3rd quarter. Emerald Mutual Fund Advisers Trust now owns 462,963 shares of the financial services provider’s stock worth $6,713,000 after purchasing an additional 14,008 shares during the last quarter. Trellus Management Company LLC bought a new position in Health Insurance Innovations in the 3rd quarter worth about $326,000. Finally, Capital World Investors bought a new position in Health Insurance Innovations in the 2nd quarter worth about $11,680,000. Hedge funds and other institutional investors own 68.11% of the company’s stock.
A number of equities research analysts have recently issued reports on HIIQ shares. Canaccord Genuity restated a “buy” rating and issued a $39.00 target price on shares of Health Insurance Innovations in a research note on Wednesday, September 13th. Cantor Fitzgerald restated a “buy” rating and issued a $38.00 target price on shares of Health Insurance Innovations in a research note on Monday, September 25th. ValuEngine upgraded shares of Health Insurance Innovations from a “buy” rating to a “strong-buy” rating in a research note on Monday, October 2nd. TheStreet lowered shares of Health Insurance Innovations from a “b-” rating to a “c” rating in a research note on Thursday, September 28th. Finally, BidaskClub lowered shares of Health Insurance Innovations from a “buy” rating to a “hold” rating in a research note on Saturday, December 9th. One analyst has rated the stock with a hold rating, eight have given a buy rating and two have given a strong buy rating to the company. Health Insurance Innovations currently has an average rating of “Buy” and an average target price of $30.86.
Health Insurance Innovations Company Profile
Health Insurance Innovations, Inc is a developer, distributor and cloud-based administrator of individual and family health insurance plans (IFPs) and supplemental products, which include short-term medical (STM) insurance plans, and guaranteed-issue and underwritten hospital indemnity plans. The Company also develops, distributes and administers supplemental products, which include a range of additional insurance and non-insurance products, such as pharmacy benefit cards, dental plans, vision plans, cancer/critical illness plans, deductible and gap protection plans, and life insurance policies that are purchased as supplements to IFP.
Receive News & Ratings for Health Insurance Innovations Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Health Insurance Innovations and related companies with MarketBeat.com's FREE daily email newsletter.